Do analysts rate RILY or BRBI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score B. Riley Financial 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BR Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, RILY or BRBI?

B. Riley Financial has higher earnings, but lower revenue than BR Biopharma. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio B. Riley Financial $967.60M 0.29 $307.42M $12.70 0.56 BR Biopharma $2.23B 0.05 $31.36M N/A N/A

Do analysts recommend BRBI or CD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BR Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Chindata Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, BRBI or CD?

BR Biopharma has higher revenue and earnings than Chindata Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BR Biopharma $2.23B 0.05 $31.36M N/A N/A Chindata Group $1.87M 139.76 -$5.10M -$0.03 N/A

Is BRBI or CD more profitable?

Company Net Margins Return on Equity Return on Assets BR Biopharma N/A N/A N/A Chindata Group N/A N/A N/A

Do analysts rate LKSP or BRBI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lake Superior Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BR Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable earnings & valuation, LKSP or BRBI?

BR Biopharma has higher revenue and earnings than Lake Superior Acquisition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lake Superior Acquisition N/A N/A N/A N/A N/A BR Biopharma $2.23B 0.05 $31.36M N/A N/A

Is LKSP or BRBI more profitable?

Company Net Margins Return on Equity Return on Assets Lake Superior Acquisition N/A N/A N/A BR Biopharma N/A N/A N/A

Do analysts rate WTF or BRBI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Waton Financial 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BR Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation and earnings, WTF or BRBI?

BR Biopharma has higher revenue and earnings than Waton Financial. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waton Financial $11.08M 12.06 -$15.15M N/A N/A BR Biopharma $2.23B 0.05 $31.36M N/A N/A

Is WTF or BRBI more profitable?

Company Net Margins Return on Equity Return on Assets Waton Financial N/A N/A N/A BR Biopharma N/A N/A N/A

Do analysts prefer SIEB or BRBI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Siebert Financial 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 BR Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, SIEB or BRBI?

BR Biopharma has higher revenue and earnings than Siebert Financial. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Siebert Financial $98.92M 0.84 $5.12M -$0.03 N/A BR Biopharma $2.23B 0.05 $31.36M N/A N/A

BR Biopharma (BRBI) Competitors

$10.12 +0.40 (+4.07%)

As of 08/26/2026 01:46 PM Eastern

Compare

BRBI vs. RILY, CD, LKSP, WTF, and SIEB

Should you buy BR Biopharma stock or one of its competitors? BR Biopharma's main competitors and comparable companies include B. Riley Financial (RILY), Chindata Group (CD), Lake Superior Acquisition (LKSP), Waton Financial (WTF), and Siebert Financial (SIEB). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "investment banking & brokerage" industry.

How does BR Biopharma compare to B. Riley Financial?

B. Riley Financial (NASDAQ:RILY) and BR Biopharma (NASDAQ:BRBI) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

B. Riley Financial has higher earnings, but lower revenue than BR Biopharma.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
B. Riley Financial	$967.60M	0.29	$307.42M	$12.70	0.56
BR Biopharma	$2.23B	0.05	$31.36M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
B. Riley Financial	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BR Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

50.2% of B. Riley Financial shares are held by institutional investors. 27.8% of B. Riley Financial shares are held by company insiders. Comparatively, 29.4% of BR Biopharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

B. Riley Financial has a net margin of 35.88% compared to BR Biopharma's net margin of 0.00%. B. Riley Financial's return on equity of 39,260.09% beat BR Biopharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
B. Riley Financial	35.88%	39,260.09%	22.99%
BR Biopharma	N/A	N/A	N/A

In the previous week, BR Biopharma had 1 more articles in the media than B. Riley Financial. MarketBeat recorded 2 mentions for BR Biopharma and 1 mentions for B. Riley Financial. B. Riley Financial's average media sentiment score of 1.80 beat BR Biopharma's score of 0.44 indicating that B. Riley Financial is being referred to more favorably in the media.

Company	Overall Sentiment
B. Riley Financial	Very Positive
BR Biopharma	Neutral

Summary

B. Riley Financial beats BR Biopharma on 7 of the 10 factors compared between the two stocks.

How does BR Biopharma compare to Chindata Group?

BR Biopharma (NASDAQ:BRBI) and Chindata Group (NASDAQ:CD) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

30.8% of Chindata Group shares are owned by institutional investors. 29.4% of BR Biopharma shares are owned by company insiders. Comparatively, 5.5% of Chindata Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, BR Biopharma had 1 more articles in the media than Chindata Group. MarketBeat recorded 2 mentions for BR Biopharma and 1 mentions for Chindata Group. Chindata Group's average media sentiment score of 1.87 beat BR Biopharma's score of 0.44 indicating that Chindata Group is being referred to more favorably in the news media.

Company	Overall Sentiment
BR Biopharma	Neutral
Chindata Group	Very Positive

BR Biopharma has higher revenue and earnings than Chindata Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BR Biopharma	$2.23B	0.05	$31.36M	N/A	N/A
Chindata Group	$1.87M	139.76	-$5.10M	-$0.03	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BR Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Chindata Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
BR Biopharma	N/A	N/A	N/A
Chindata Group	N/A	N/A	N/A

Summary

BR Biopharma beats Chindata Group on 4 of the 7 factors compared between the two stocks.

How does BR Biopharma compare to Lake Superior Acquisition?

Lake Superior Acquisition (NASDAQ:LKSP) and BR Biopharma (NASDAQ:BRBI) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends, media sentiment and analyst recommendations.

BR Biopharma has higher revenue and earnings than Lake Superior Acquisition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lake Superior Acquisition	N/A	N/A	N/A	N/A	N/A
BR Biopharma	$2.23B	0.05	$31.36M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lake Superior Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BR Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
Lake Superior Acquisition	N/A	N/A	N/A
BR Biopharma	N/A	N/A	N/A

In the previous week, Lake Superior Acquisition and Lake Superior Acquisition both had 2 articles in the media. Lake Superior Acquisition's average media sentiment score of 0.46 beat BR Biopharma's score of 0.44 indicating that Lake Superior Acquisition is being referred to more favorably in the media.

Company	Overall Sentiment
Lake Superior Acquisition	Neutral
BR Biopharma	Neutral

Summary

Lake Superior Acquisition and BR Biopharma tied by winning 1 of the 2 factors compared between the two stocks.

How does BR Biopharma compare to Waton Financial?

Waton Financial (NASDAQ:WTF) and BR Biopharma (NASDAQ:BRBI) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and institutional ownership.

Company	Net Margins	Return on Equity	Return on Assets
Waton Financial	N/A	N/A	N/A
BR Biopharma	N/A	N/A	N/A

In the previous week, BR Biopharma had 1 more articles in the media than Waton Financial. MarketBeat recorded 2 mentions for BR Biopharma and 1 mentions for Waton Financial. Waton Financial's average media sentiment score of 1.87 beat BR Biopharma's score of 0.44 indicating that Waton Financial is being referred to more favorably in the media.

Company	Overall Sentiment
Waton Financial	Very Positive
BR Biopharma	Neutral

BR Biopharma has higher revenue and earnings than Waton Financial.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waton Financial	$11.08M	12.06	-$15.15M	N/A	N/A
BR Biopharma	$2.23B	0.05	$31.36M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waton Financial	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BR Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

BR Biopharma beats Waton Financial on 3 of the 5 factors compared between the two stocks.

How does BR Biopharma compare to Siebert Financial?

Siebert Financial (NASDAQ:SIEB) and BR Biopharma (NASDAQ:BRBI) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, analyst recommendations, institutional ownership, dividends, valuation and profitability.

1.5% of Siebert Financial shares are held by institutional investors. 46.0% of Siebert Financial shares are held by company insiders. Comparatively, 29.4% of BR Biopharma shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Siebert Financial	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
BR Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

BR Biopharma has higher revenue and earnings than Siebert Financial.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Siebert Financial	$98.92M	0.84	$5.12M	-$0.03	N/A
BR Biopharma	$2.23B	0.05	$31.36M	N/A	N/A

BR Biopharma has a net margin of 0.00% compared to Siebert Financial's net margin of -1.07%. BR Biopharma's return on equity of 0.00% beat Siebert Financial's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Siebert Financial	-1.07%	-1.25%	-0.15%
BR Biopharma	N/A	N/A	N/A

In the previous week, Siebert Financial had 2 more articles in the media than BR Biopharma. MarketBeat recorded 4 mentions for Siebert Financial and 2 mentions for BR Biopharma. Siebert Financial's average media sentiment score of 0.78 beat BR Biopharma's score of 0.44 indicating that Siebert Financial is being referred to more favorably in the media.

Company	Overall Sentiment
Siebert Financial	Positive
BR Biopharma	Neutral

Summary

Siebert Financial and BR Biopharma tied by winning 5 of the 10 factors compared between the two stocks.

Get BR Biopharma News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BRBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BRBI vs. The Competition

Export

Metric	BR Biopharma	Capital Markets Industry	Finance Sector	NASDAQ Exchange
Market Cap	$114.79M	$5.73B	$14.10B	$12.81B
Dividend Yield	5.24%	7.39%	5.89%	11.02%
P/E Ratio	N/A	32.55	26.71	24.12
Price / Sales	0.05	1,235.69	518.26	89.48
Price / Cash	3.45	48.45	39.14	53.65
Price / Book	0.75	2.13	2.18	6.20
Net Income	$31.36M	$417.46M	$1.31B	$348.07M
7 Day Performance	10.68%	0.84%	1.51%	1.11%
1 Month Performance	-12.11%	2.08%	2.57%	4.27%
1 Year Performance	N/A	8.05%	11.60%	16.48%

BR Biopharma Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BRBI BR Biopharma	0.6824 of 5 stars	$10.12 +4.1%	N/A	N/A	$114.79M	$2.23B	N/A	N/A	Short Interest Increase Gap Up
RILY B. Riley Financial	1.0215 of 5 stars	$7.23 +1.0%	N/A	+40.7%	$290.65M	$967.60M	0.57	1,380	Positive News
CD Chindata Group	0.1667 of 5 stars	$3.46 -5.2%	N/A	N/A	$274.86M	$1.87M	N/A	1,450	Positive News
LKSP Lake Superior Acquisition	N/A	$10.20 +0.0%	N/A	N/A	$199.11M	N/A	N/A	2	Positive News Short Interest Increase
WTF Waton Financial	0.5229 of 5 stars	$2.88 -1.2%	N/A	-42.4%	$138.69M	$11.08M	N/A	31	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BRBI) was last updated on 8/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BR Biopharma (BRBI) Competitors

BRBI vs. RILY, CD, LKSP, WTF, and SIEB

How does BR Biopharma compare to B. Riley Financial?

Summary

How does BR Biopharma compare to Chindata Group?

Summary

How does BR Biopharma compare to Lake Superior Acquisition?

Summary

How does BR Biopharma compare to Waton Financial?

Summary

How does BR Biopharma compare to Siebert Financial?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BRBI vs. The Competition

BR Biopharma Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

BR Biopharma (BRBI) Competitors

BRBI vs. RILY, CD, LKSP, WTF, and SIEB

How does BR Biopharma compare to B. Riley Financial?

Which has preferable valuation & earnings, RILY or BRBI?

Do analysts rate RILY or BRBI?

Do institutionals & insiders hold more shares of RILY or BRBI?

Is RILY or BRBI more profitable?

Does the media prefer RILY or BRBI?

Summary

How does BR Biopharma compare to Chindata Group?

Do insiders & institutionals hold more shares of BRBI or CD?

Does the media prefer BRBI or CD?

Which has better valuation & earnings, BRBI or CD?

Do analysts recommend BRBI or CD?

Is BRBI or CD more profitable?

Summary

How does BR Biopharma compare to Lake Superior Acquisition?

Which has preferable earnings & valuation, LKSP or BRBI?

Do analysts rate LKSP or BRBI?

Is LKSP or BRBI more profitable?

Does the media favor LKSP or BRBI?

Summary

How does BR Biopharma compare to Waton Financial?

Is WTF or BRBI more profitable?

Does the media prefer WTF or BRBI?

Which has stronger valuation and earnings, WTF or BRBI?

Do analysts rate WTF or BRBI?

Summary

How does BR Biopharma compare to Siebert Financial?

Do insiders & institutionals hold more shares of SIEB or BRBI?

Do analysts prefer SIEB or BRBI?

Which has higher earnings and valuation, SIEB or BRBI?

Is SIEB or BRBI more profitable?

Does the media favor SIEB or BRBI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BRBI vs. The Competition

BR Biopharma Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools